Impairment of right ventricular longitudinal strain associated with severity of pneumonia in patients recovered from COVID-19.
COVID-19
Pneumonia
Recovery
Right ventricle
Speckle tracking echocardiography
Journal
The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
20
01
2021
accepted:
01
03
2021
pubmed:
12
4
2021
medline:
5
8
2021
entrez:
11
4
2021
Statut:
ppublish
Résumé
Myocardial injury caused by COVID-19 was reported in hospitalized patients previously. But the information about cardiac consequences of COVID-19 after recovery is limited. The aim of the study was comprehensive echocardiography assessment of right ventricular (RV) in patients recovered from COVID-19. This is a prospective, single-center study. After recovery from COVID-19, echocardiography was performed in consecutive 79 patients that attended follow-up visits from July 15 to November 30, 2020. According to the recovery at home vs hospital, patients were divided into two groups: home recovery (n = 43) and hospital recovery (n = 36). Comparisons were made with age, sex and risk factor-matched control group (n = 41). In addition to conventional echocardiography parameters, RV global longitudinal strain (RV-GLS) and RV free wall strain (RV-FWS) were determined using 2D speckle-tracking echocardiography (2D STE). Of the 79 patients recovered from COVID-19, 43 (55%) recovered at home, while 36 (45%) required hospitalization. The median follow-up duration was 133 ± 35 (87-184) days. In patients recovered from hospital, RV-GLS and RV-FWS were impaired compared to control group (RV-GLS: -17.3 ± 6.8 vs. -20.4 ± 4.9, respectively [p = 0.042]; RV-FWS: -19.0 ± 8.2 vs. -23.4 ± 6.2, respectively [p = 0.022]). In subgroup analysis, RV-FWS was impaired in patients severe pneumonia (n = 11) compared to mild-moderate pneumonia (n = 28), without pneumonia (n = 40) and control groups (-15.8 ± 7.6 vs. -21.6 ± 7.6 vs. -20.8 ± 7.7 vs. -23.4 ± 6.2, respectively, [p = 0.001 for each]) and RV-GLS was impaired compared to control group (-15.2 ± 6.9 vs. -20.4 ± 4; respectively, [p = 0.013]). A significant correlation was detected between serum CRP level at hospital admission and both RV-GLS and RV-FWS (r = 0.285, p = 0.006; r = 0.294, p = 0.004, respectively). Age (OR 0.948, p = 0.010), male gender (OR 0.289, p = 0.009), pneumonia on CT (OR 0.019, p = 0.004), and need of steroid in treatment (OR 17.424, p = 0.038) were identifed as independent predictors of impaired RV-FWS (> -18) via multivariate analysis. We demonstrated subclinic dysfunction of RV by 2D-STE in hospitalized patients in relation to the severity of pneumonia after recovery from COVID-19. 2D-STE supplies additional information above standard measures of RV in this cohort and can be used in the follow-up of these patients.
Identifiants
pubmed: 33839981
doi: 10.1007/s10554-021-02214-2
pii: 10.1007/s10554-021-02214-2
pmc: PMC8036243
doi:
Substances chimiques
Glucocorticoids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2387-2397Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Minerva Anestesiol. 2012 Aug;78(8):941-8
pubmed: 22672932
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
Circ Cardiovasc Imaging. 2018 Jan;11(1):e006894
pubmed: 29321212
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Dis Mon. 2020 Sep;66(9):101068
pubmed: 32907701
JAMA Cardiol. 2020 Nov 1;5(11):1281-1285
pubmed: 32730555
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Circulation. 2020 May 19;141(20):1648-1655
pubmed: 32200663
Can J Cardiol. 2020 Aug;36(8):1203-1207
pubmed: 32474111
JACC Cardiovasc Imaging. 2020 Nov;13(11):2459-2461
pubmed: 32426088
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
JAMA Cardiol. 2020 Nov 1;5(11):1265-1273
pubmed: 32730619
J Am Soc Echocardiogr. 2017 Oct;30(10):937-946.e6
pubmed: 28803684
Int J Cardiovasc Imaging. 2021 Jan;37(1):135-144
pubmed: 32803484
Heart. 2010 May;96(9):716-22
pubmed: 20424157
Eur J Echocardiogr. 2011 Mar;12(3):167-205
pubmed: 21385887
Intensive Care Med. 2009 Jan;35(1):69-76
pubmed: 18839137
J Am Soc Echocardiogr. 2021 Feb;34(2):193-195
pubmed: 33243582
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
Eur Heart J. 2020 Oct 14;41(39):3827-3835
pubmed: 32968776
JACC Cardiovasc Imaging. 2020 Nov;13(11):2287-2299
pubmed: 32654963
J Am Coll Cardiol. 2020 Oct 27;76(17):1965-1977
pubmed: 33092732
JACC Cardiovasc Imaging. 2020 Nov;13(11):2330-2339
pubmed: 32763118
Echocardiography. 2015 Jun;32(6):966-74
pubmed: 25287078
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
J Am Soc Echocardiogr. 2019 Jan;32(1):1-64
pubmed: 30282592